Modified intensity and location of cortical layer marker proteins following Pg-OMV exposure <i>in utero.</i> by Adrienne J. Bradley (20861948)

Subjects:

Data for figures. by Adrienne J. Bradley (20861948)

Subjects:

Comparison of study groups based on patients’ variables before and after administration of study drugs. by Nadia Gul (249538)

Subjects:

Flow chart of patient’s recruitment and participation. by Nadia Gul (249538)

Subjects:

Comparative analyses of group 1 vs group 2 based on various patient characteristics. by Nadia Gul (249538)

Subjects:

Frequency of hypoglycemic episodes in group 1 vs group 2. by Nadia Gul (249538)

Subjects:

Demographics and baseline characteristics of patients. by Nadia Gul (249538)

Subjects:

Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration. by Nadia Gul (249538)

Subjects:

Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the <i>OCT</i> Gene, which is Highly Expressed in the Spermathecal... by Wen-Han Yan (20539256)

Subjects:

Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the <i>OCT</i> Gene, which is Highly Expressed in the Spermathecal... by Wen-Han Yan (20539256)

Subjects:

Insulin-free survival in patients with and without FHD. by Clemens Plattner (21567706)

Subjects:

Event-free survival analysis of microvascular outcome. by Clemens Plattner (21567706)

Subjects:

Cascade of care by HCV testing model. by Bao Vu Ngoc (14551955)

Subjects:

Proportion of first-time testers by key population group. by Bao Vu Ngoc (14551955)

Subjects:

Comparative cost analysis of HCVST and PL-HCVT models (in US$). by Bao Vu Ngoc (14551955)

Subjects:

Incremental costs per month for different HCV testing models. by Bao Vu Ngoc (14551955)

Subjects:

Characteristics of propensity score matched groups. by Clemens Plattner (21567706)

Subjects:

Event-free survival analysis of macrovascular outcome. by Clemens Plattner (21567706)

Subjects:

Comparative costs of HCVST and PL-HCVT models in sensitivity analysis (in US$). by Bao Vu Ngoc (14551955)

Subjects:

HCV positivity rate by key population group opting for HCVST and standard HCVT. by Bao Vu Ngoc (14551955)

Subjects: